Drug Repurposing

Fuatilia
Lab scene illustrating breakthrough Alzheimer's drug candidates: Zostavax vaccine, sildenafil (Viagra), riluzole with brain model and expert panel.
Àwòrán tí AI ṣe

Experts flag shingles vaccine, sildenafil and riluzole as leading Alzheimer’s repurposing candidates

Ti AI ṣe iroyin Àwòrán tí AI ṣe Ti ṣayẹwo fun ododo

A University of Exeter-led study funded by Alzheimer’s Society has identified three already-approved medicines—the shingles vaccine Zostavax, sildenafil (Viagra) and riluzole—as top “priority” candidates to be tested in clinical trials for Alzheimer’s disease, after a structured review of 80 existing drugs by an international expert panel.

Ojú-ìwé yìí nlo kuki

A nlo kuki fun itupalẹ lati mu ilọsiwaju wa. Ka ìlànà àṣírí wa fun alaye siwaju sii.
Kọ